日本药品价值定价的价值要素和方法:系统性审查
Akina Takami1,2, Masafumi Kato1, Hisato Deguchi1
1Market Access, Public Affairs & Patient Experience, Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
基于价值的定价 (VBP) 优化了药物成本,但缺乏关于价值元素和方法的共识. 需要进一步的研究,以实现跨疾病适用的多功能VBP方法.
科学领域:
- 卫生经济学 卫生经济学
- 制药价格的制定 制药价格的制定
- 药物价值评估 药物价值评估
背景情况:
- 基于价值的定价 (VBP) 是一种优化药品成本的策略.
- 目前的VBP在定义价值元素和选择适当的定价方法方面缺乏共识.
- 这项研究解决了对标准化VBP方法的需求.
结论:
- 目前在VBP中使用的是传统和更广泛的价值元素.
- 一种简单,多功能的VBP方法对于在各种疾病中广泛应用至关重要.
- 需要进一步的研究来开发一种有效地纳入更广泛价值范围的VBP方法.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
相关概念视频
Bioequivalence: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Regulation
Drug Nomenclature
Drug Control Governance: Regulatory Bodies and Their Impact
